<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01587326</url>
  </required_header>
  <id_info>
    <org_study_id>BAFH-101-05</org_study_id>
    <secondary_id>BAFH</secondary_id>
    <nct_id>NCT01587326</nct_id>
  </id_info>
  <brief_title>The Effects of Escitalopram on Cytokines</brief_title>
  <acronym>BAFH</acronym>
  <official_title>The Effects of Escitalopram on Cytokines in Depressive Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beitou Armed Forces Hospital, Taipei, Taiwan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beitou Armed Forces Hospital, Taipei, Taiwan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The association of cytokines with escitalopram has not been investigated in patients with
      major depressive disorder (MDD). Hence, the investigators will examine this association.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In addition to serotonin, inflammatory process has been suggested in the development of major
      depressive disorder (MDD) and in its associated treatment. Escitalopram is an antidepressant
      that has been widely used in patients with MDD because of the promising results. The
      association of cytokines with escitalopram has not been investigated in patients with MDD.
      Hence, the investigators will examine this association.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">April 2013</completion_date>
  <primary_completion_date type="Anticipated">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The changes in cytokines</measure>
    <time_frame>Week 0, Week 4</time_frame>
    <description>Hamilton Depression Rating Scale, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, IL-17A, G-CSF, GM-CSF, IFN-γ, MCP-1, MIP-1β, TNF-α</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The changes in Hamilton Depression Rating Scale</measure>
    <time_frame>week 0, week 4</time_frame>
    <description>Hamilton Depression Rating Scale, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, IL-17A, G-CSF, GM-CSF, IFN-γ, MCP-1, MIP-1β, TNF-α</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Escitalopram</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Escitalopram 10 mg/d to 20 mg/d</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Escitalopram</intervention_name>
    <description>escitalopram 10 mg/d to 20 mg/d</description>
    <arm_group_label>Escitalopram</arm_group_label>
    <other_name>Lexapro</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. DSM-IV-defined Major depressive disorder, single episode

          2. Age 20-65

          3. Drug-naive

          4. Hamilton Depression Rating Scale exceeding 14 scores

        Exclusion Criteria:

          1. Major medical disorders

          2. Substance use

          3. Pregnant

          4. Allergy to escitalopram
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peishen Ho, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Beitou Armed Forces Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pei-Shen Ho, M.D.</last_name>
    <phone>+886-2-28959808</phone>
    <email>luke_and_tina@yahoo.com.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beitou Armed Forces Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chih-Sung Liang, M.D.</last_name>
      <phone>+886-2-8959808</phone>
      <email>lcsyfw@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2012</study_first_submitted>
  <study_first_submitted_qc>April 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2012</study_first_posted>
  <last_update_submitted>May 13, 2012</last_update_submitted>
  <last_update_submitted_qc>May 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cytokine, depression, escitalopram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citalopram</mesh_term>
    <mesh_term>Dexetimide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

